$SHMN(.0007)~300 Generic Drugs,NO R/S,Buyback,Low Float

New Post Public Reply Private Reply Replies (0) Message Board
Greenland12 stockstein #7959
533
$SHMN(.0007)~300 Generic Drugs,NO R/S,Buyback,Low Float

1) SHMN~ SOHM, Inc., is a growing generic pharmaceutical manufacturing and marketing company with a vision “Globalè Prospèro” that tries to build continuous growth. SOHM manufacturing and marketing targets the rapidly growing healthcare segments such as Nutraceuticals, Cosmeceuticals, and other major therapeutic segments. SOHM is headquartered in North America with manufacturing alliances in India as well as a strategic alliance with US manufacturing facilities . Although SOHM’s generic pharmaceuticals were exported globally and were introduced to the USA in early 2013, SOHM continues its focus on distribution to emerging markets in Africa, Latin America, and Southeast Asia.
To know more about SOHM, Inc., visit

Website: https://www.sohm.com/

Twitter: https://twitter.com/sohminc?lang=en

Facebook: https://www.facebook.com/sohminc/


2) SHMN~ Pharma Company in the FDA list: # 009303848 Sohm,Inc., USA

https://www.fda.gov/downloads/AboutFDA/Workin...540392.pdf


3) SHMN has produces 300 Generic Drugs

https://investorshub.advfn.com/boards/read_ms...=158115031

The Company’s strategic manufacturing facility enables low production costs without compromising quality. SHMN develops, manufactures and markets generic pharmaceuticals in various dosage forms, including tablets and capsules, creams and topicals, ointments, liquids and injectables. At present, SHMN has global licenses to manufacture more than 15 products and approximately 300 generic drugs and product formulations for distribution.

page 4

https://backend.otcmarkets.com/otcapi/company...65/content

***************************************************************************

~~~SOME OF THEIR DRUGS REVIEWED BY DRUGS.COM ~~~~

https://www.drugs.com/otc/126942/sohmed-pain-relief-pm.html

https://www.drugs.com/otc/126788/sohmed-pain-reliever.html

https://www.drugs.com/otc/126641/sohmed-cold-relief.html

https://www.drugs.com/otc/126645/sohmed-acid-reducer.html

https://www.drugs.com/otc/126638/sohmed-allergy.html

https://www.drugs.com/otc/126662/sohmed-alertness-aid.html

https://www.drugs.com/otc/128088/salic-2.html

************************************************************************

4) SHMN~ NDC Labeler Drug List

The following table lists the NDC drug codes by SOHM Inc.:
NDC Trade Name Labeler Name
50405-0110 Salic-2 SOHM Inc.
50405-0002 SohMed Acid Reducer SOHM Inc.
50405-0005 SohMed Alertness Aid SOHM Inc.
50405-0004 SohMed Allergy SOHM Inc.
50405-0003 SohMed Allergy Sinus SOHM Inc.
50405-0006 SohMed Cold Relief SOHM Inc.
50405-0001 SohMed Extra Strength SOHM Inc.
50405-0007 SohMed Pain Relief PM SOHM Inc.
50405-0008 SohMed Pain Reliever SOHM Inc.
50405-0009 SohMed Sinus Sohm Inc.

https://www.findacode.com/ndc/labelers/SOHM_Inc.


5) September 11, 2020 News : The company has continued with the development and introduction of 5 new products [/b] into its product line while maintaining consistency with the company’s outlook and strategic plan. All manufacturing is in the USA . Our products are currently being marketed and sold in the USA.

1. Nail Renovar-Nail Fungus treatment. This global market is projected to reach 6.7 Billion by 2026.

New Website for https://nailrenovar.com

2. Hand Sanitizer Spray with Aloe Vera- Personal Care
3. Anti-Microbial Multi-Purpose Spray- Personal Care
4. Anti-Microbial Hand Soap- Personal Care and
5. Non-Alcoholic Hand Sanitizer Gel-Personal Care

ONLINE SHOP : http://store.sohm.com

https://www.youtube.com/watch?v=zCzskTxKJf8&a...e=youtu.be

SOHM will be introducing some additional new products in-line with its Globalè Prospèro Vision 2024 in the coming weeks/months .

https://www.sohm.com/2020/09/11/sohm-inc-anno...er-update/


6) SHMN~ 20,000 sq ft. FDA certified Sought California Facility

CEO Baron Night: “Our manufacturing alliance partner operates a 20,000 square ft. Southern California facility that is FDA certified and OTC and Prescription (Rx) drug and cGMP compliant. They specialize in product development and the manufacture of skin, hair, and body care products as well as color cosmetics. This manufacturing house not only has over 4500 formulas available and accessible to us but, has the capability to modify these formulas to suit our as well as our client’s needs.”

https://www.sohm.com/2018/12/21/sohm-inc-sign...DA.twitter


7) SHMN~ T he most recent financials shows Revenue growth 268% and $52,038 Dollars Net profit

https://www.sohm.com/2018/11/26/sohm-inc-anno...vE.twitter

PAGE 15
https://backend.otcmarkets.com/otcapi/company...65/content


8) SHMN Share structure as of 09/10/2020

Authorized: 2,000,000,000
Outstanding Shares: 1,575,576,407
Restricted: 327,792,017
UnRestricted 1,247,784,390

https://www.otcmarkets.com/stock/SHMN/security


SHMN share structure pretty much not changed last 5 years

SHMN share structure as of 12/31/2015

Authorized 2,000,000,000
Outstanding shares 1,546,636,529

page 14

https://backend.otcmarkets.com/otcapi/company...60/content

September 11, 2020 NEWS: The company has not issued any shares to anyone including promoters, officers, directors, and/or employees in the last several years .
[/b]
https://www.sohm.com/2020/09/11/sohm-inc-anno...er-update/


9) SHMN~ Insiders holds 178,186,086 common shares

(i) Name: Swati Shah ; 5% or more shareholder
(ii) Business Address: 7889 Garden Park St., Chino, CA 91708
(iii) Number and Class of Shares Beneficially Owned: 96,180,086 common shares (iv) Shares are restricted pursuant to Rule 144
(v) Acquired shares for services rendered

(i) Name: BHAT Family Trust ., 5% or more shareholder
(ii) Business Address: 6920 Knott Ave., Suite C, Buena Park, CA 90621
(iii) Number and Class of Shares Beneficially Owned: 82,000,000 Common Shares (iv) Shares do not bear the restricted legend
(v) Shares acquired through an investment company

https://backend.otcmarkets.com/otcapi/company...15/content


10) SHMN~ Confirmed again NO REVERSE SPLIT on September 11, 2020 [/b]

Mr. Night-CEO has further stated that the company management has no plans to conduct any reverse split of shares as announced in January of 2018.

https://www.sohm.com/2020/09/11/sohm-inc-anno...er-update/

The management is not intending to conduct any reverse split but in coming days/weeks and months, the company will be considering a share buyback program.

https://www.otcmarkets.com/stock/SHMN/news/EQ...?id=215967


11) SHMN has 154 million SHARE BUYBACK until February 28, 2021

The buyback program as currently planned will take place between March 1, 2019 and February 28, 2021, with an initial target of 10% of the current outstanding shares of SOHM, Inc. common stock (approximately 154,000,000 shares), with not less than 50% to be retired. Pursuant to the safe harbor provisions of Rule 10b-18, these shares will be acquired by SOHM on the public market, and will be subject to the manner of purchase, timing, price, and volume restrictions specified therein.

https://www.otcmarkets.com/stock/SHMN/news/So...?id=219520

CEO Baron Night confirmed on September 11, 2020: The company and management will honor all previously announced commitments made to all stakeholders.

https://www.sohm.com/2020/09/11/sohm-inc-anno...er-update/


12) SHMN CEO Baron Night's Video blog Speech

https://www.youtube.com/watch?v=KCtuAwTuCGU&t=1s

SHMN CEO Baron Night is an expert In financial sector for more than 40 years in different industries, SOHM looking forward to getting the expertise of him

https://www.sohm.com/2018/09/10/sohm-names-fi...dc.twitter


13) SHMN~ Linkedin shows SOHM has 41 employees , 35 of them in India and 6 of them in USA

https://www.linkedin.com/company/sohm-inc./people/


14) SHMN Latest Articles

SOHM, Inc. Announce Interim Shareholder update

09/11/2020 posted in Press Releases

Chino Hills, CA – September 11, 2020 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, ...

SOHM, INC., ANNOUNCES SHARES BUYBACK PROGRAM

02/26/2019 posted in Press Releases

Chino Hills, CA – February 26, 2019 – SOHM, Inc. (Pink Sheets: SHMN), a generic Pharmaceutical, Nutraceutical, and Cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories, ...

https://www.sohm.com/news/


For more information, please contact:
SOHM, Inc.
714-522-6700
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 5

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Updated Category News Views 5

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 0

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
S&T Bancorp Hits Record Highs in Q3 2026

Updated Category News Views 3

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 5

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Tairex's AI System Targets Global Healthcare Gaps

Updated Category News Views 6

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 1

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 7

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading

Top 5 Most Recently Viewed Articles

Freeport-McMoRan Legal Update: Key Actions for Investors

Updated Category News Views 256

Understanding the Importance of Class Actions for Investors In the world of investing, class actions serve as crucial tools for holding companies accountable for their actions. Investors, particularly those who have purchased stocks during a defined time frame, like those involved with Freeport-McMoRan Inc. (NYSE: FCX), stand to benefit significantly from these legal...

Continue Reading
Investigation into ADMA Biologics Growth Potential and Risks

Updated Category News Views 58

Insights into ADMA Biologics and Ongoing Investigations Investors interested in ADMA Biologics, Inc. should be aware that the company is currently under investigation for potential securities fraud, prompting discussions about recovery options for those impacted. Understanding these developments can offer investors crucial insights into the company's future prospects and...

Continue Reading
Kuehn Law Assists Zentalis Pharmaceuticals Investors in Rights Endeavors

Updated Category News Views 82

Understanding Your Rights as a Zentalis Investor Kuehn Law, a prominent shareholder litigation firm, is currently investigating the actions of the management team at Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL). The focus lies on whether certain officers and directors have acted in ways that undermine their fiduciary responsibilities. These responsibilities include...

Continue Reading
Navigating Market Challenges: Insights into Recent Trends

Updated Category News Views 180

Understanding Current Market Dynamics In a time of significant market fluctuations, risk assets are facing pressure due to a complex mix of economic indicators and investor sentiment. Recent developments in US equities have created a landscape where volatility is the norm. This analysis will delve into various market segments, focusing on key events that shape the current...

Continue Reading
Harnessing Waste Heat: The Future of Clean Energy Deployment

Updated Category News Views 102

Harnessing Waste Heat to Drive Clean Energy Solutions ATS Energy, a trailblazer in renewable energy technology, is making significant strides in turning industrial waste heat into valuable electricity. This revolutionary process not only enhances energy efficiency but also contributes to a more sustainable future. The introduction of the bipartisan Waste Heat to Wattage...

Continue Reading